(Q41934949)

14 October 2017

title

Specific inhibition of cyclic AMP-dependent protein kinase by the antimalarial halofantrine and by related phenanthrenes (English)

1 reference

14 October 2017

0 references

1 reference

Wang BH

1

1 reference

14 October 2017

Ternai B

series ordinal

2

1 reference

14 October 2017

Polya GM

series ordinal

3

1 reference

14 October 2017

publication date

1 August 1994

1 reference

Biological chemistry Hoppe-Seyler

14 October 2017

published in

1 reference

14 October 2017

volume

375

1 reference

14 October 2017

issue

8

1 reference

14 October 2017

page(s)

527-535

1 reference

The structure and regulation of protein phosphatases

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Potent selective inhibitors of protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

The biochemistry of P-glycoprotein-mediated multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Chelerythrine is a potent and specific inhibitor of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Characterization of specific binding sites for [3H]-staurosporine on various protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Reversal of chloroquine resistance in Plasmodium falciparum by verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Cardiac effects of antimalarial treatment with halofantrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Inhibition of eukaryote signal-regulated protein kinases by plant-derived catechin-related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Growth factor and oncogene signalling pathways as targets for rational anticancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Calcium and calmodulin antagonists inhibit human malaria parasites (Plasmodium falciparum): implications for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

21 January 2018

Halofantrine sensitivity

1 reference

https://api.crossref.org/works/10.1515%2FBCHM3.1994.375.8.527

10.1515/BCHM3.1994.375.8.527

21 January 2018

Identifiers

DOI

1 reference

14 October 2017

1 reference